Publication & Citation Trends
Most Cited Works
Publications
5 total
Abstract 1063: Serum neuron-specific enolase (NSE) as a biomarker of central nervous system (CNS) metastases: Updated results from the BrainStorm program (Oncodistinct 006)
Cited by 0
Semantic Scholar
Adjuvant Pertuzumab and Trastuzumab in Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the APHINITY Trial: Third Interim Overall Survival Analysis With Efficacy Update PDF
Cited by 21
OpenAlex
Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial PDF
Cited by 21
OpenAlex
VP6-2022: Adjuvant pertuzumab and trastuzumab in patients with early HER-2 positive breast cancer in APHINITY: 8.4 years' follow-up PDF
Cited by 51
OpenAlex
Timelines to initiate a phase III trial across the globe: a sub-analysis of the APHINITY trial OA
Cited by 4
Semantic Scholar
Patient-reported function, health-related quality of life, and symptoms in APHINITY: pertuzumab plus trastuzumab and chemotherapy in HER2-positive early breast cancer PDF
Cited by 6
OpenAlex
Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab (P+T) in the APHINITY trial.
Cited by 1
OpenAlex
Abstract PS7-21: Timelines to initiate an adjuvant phase III trial across the globe: A sub-analysis of the APHINITY trial
Cited by 1
Semantic Scholar
Research Topics
HER2/EGFR in Cancer Research
(5)
Cancer Treatment and Pharmacology
(3)
Breast Cancer Treatment Studies
(2)
Peptidase Inhibition and Analysis
(2)
Monoclonal and Polyclonal Antibodies Research
(1)
Frequent Co-Authors
Affiliations
Université Libre de Bruxelles
Institut Jules Bordet
Breast International Group